The discussion held in Debrecen between the Vice Dean of Taipei Medical University and the Dean of the Faculty of Pharmacy at the University of Debrecen focused on the results achieved so far and the tasks ahead in the development of a new type of drug that is hoped to bring a breakthrough in the chemotherapy treatment of cancerous lesions.
News
Nine PhD students from the Faculty of Pharmacy at the University of Debrecen visited China Pharmaceutical University in Nanjing, a city with a population of over 9 million. The primary goal of the trip was to deepen professional and scientific cooperation between the two institutions.
An associate professor from the Faculty of Agricultural and Food Sciences and Environmental Management of the University of Debrecen (UD MÉK) has become the first Hungarian researcher to visit Bouvet Island, which is part of the Norwegian Antarctic Territory. As a member of an international scientific expedition, László Radócz spent two weeks on the glacier-covered island that has seen less than 200 visitors so far, fewer than outer space has.
An academic career model designed and built from high school onward, state-of-the-art laboratory facilities and direct connections to the international elite are combined to make up the objective of an agreement signed by the University of Debrecen and the city of Debrecen with Hungary’s National Academy of Scientist Education. Nobel Prize-winning American cell biologist Randy Schekman also attended the signing ceremony and gave an inspiring talk to Debrecen’s future researchers at our Learning Center.
BMW Group Plant in Debrecen and the University of Debrecen are determined about further strengthening their collaboration. According to a new agreement between them, the general practitioner (GP) services of our Clinical Center are available as of now to plant employees for their primary healthcare needs. This latest agreement clearly reveals the value-creating effect of this cooperation between higher education and industry.
Groups of researchers, teachers and artists, who work in the fields of music education, musicology and musical performance, discussed their experiences and professional achievements in order to be able to define the tasks for music education in the coming years at the sixth international conference titled “Music and Society.” The conference participants also had a chance to learn about the latest research findings in this specific field.
At present, there is a group of young Uzbek pharmacists participating in an internship at the Faculty of Pharmacy at the University of Debrecen. These visitors from Central Asia are currently familiarizing themselves with the scientific work conducted here in Debrecen, gaining insight into state-of-the-art laboratory methods, taking part in current research projects and conducting studies related to their own research topics.
There are questions and problems around us that even a grade school pupil can understand, but answering or solving them would take decades or perhaps centuries even for the greatest minds of the world. István Pink, a researcher at the University of Debrecen, and his Japanese colleague Takafumi Miyazaki, have found an answer to a question just like that, which has been open for 30 or 40 years. Their solution was published in one of the world’s most respected and celebrated journals in its field, the American Journal of Mathematics.
A recent examination related to special immune cells in the placenta conducted by research scientists at the University of Debrecen could contribute to a more profound understanding of processes and complications during pregnancy and, in the long run, even to the development of new therapeutic options. It was this group of scientists in Debrecen that were the first to provide a comprehensive genetic picture of the so-called Hofbauer cells. The findings of their international collaborative research project were published in the prestigious international journal JCI Insight.
The University of Debrecen has elevated its level of cooperation with one of the largest global companies specializing in biotechnology to a higher notch in order to provide more efficient services in patient care. The agreement, which was signed on Wednesday, aims, among other things, at supporting the early detection of diseases, the strengthening of appropriate diagnostic pathways and improving patient management in areas that are regarded widespread diseases in Hungary, such as cancer, cardiovascular and chronic respiratory diseases.